Morgan Stanley Maintains Equal-Weight on Solventum, Lowers Price Target to $55
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood maintains an Equal-Weight rating on Solventum (NYSE:SOLV) but lowers the price target from $70 to $55.
July 15, 2024 | 4:49 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained its Equal-Weight rating on Solventum but has lowered the price target from $70 to $55, indicating a less optimistic outlook.
The lowered price target from $70 to $55 by Morgan Stanley suggests a less optimistic outlook for Solventum, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100